A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Novartis Ag stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 3,115 shares of NVS stock, worth $323,368. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,115
Previous 3,997 22.07%
Holding current value
$323,368
Previous $425,000 15.76%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$106.13 - $120.89 $93,606 - $106,624
-882 Reduced 22.07%
3,115 $358,000
Q2 2024

Aug 09, 2024

BUY
$92.57 - $107.37 $370,002 - $429,157
3,997 New
3,997 $425,000
Q4 2023

Feb 06, 2024

SELL
$92.27 - $101.54 $59,052 - $64,985
-640 Reduced 22.87%
2,159 $217,000
Q3 2023

Nov 02, 2023

BUY
$94.73 - $105.13 $265,149 - $294,258
2,799 New
2,799 $285,000
Q4 2022

Feb 07, 2023

BUY
$75.55 - $92.52 $184,115 - $225,471
2,437 New
2,437 $221,000
Q2 2022

Aug 02, 2022

SELL
$80.52 - $93.75 $205,567 - $239,343
-2,553 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $8,251 - $9,333
-103 Reduced 3.88%
2,553 $224,000
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $211,683 - $234,073
2,656 New
2,656 $232,000
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $182,865 - $215,649
-2,190 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $170,973 - $206,801
2,190 New
2,190 $207,000
Q2 2020

Aug 12, 2020

SELL
$80.93 - $91.1 $214,059 - $240,959
-2,645 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$70.67 - $99.01 $34,062 - $47,722
-482 Reduced 15.41%
2,645 $218,000
Q4 2019

Feb 13, 2020

SELL
$84.35 - $95.37 $75,155 - $84,974
-891 Reduced 22.18%
3,127 $296,000
Q3 2019

Nov 13, 2019

BUY
$85.54 - $94.26 $343,699 - $378,736
4,018 New
4,018 $349,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Portfolio

Follow Empirical Financial Services, LLC D.B.A. Empirical Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Financial Services, LLC D.B.A. Empirical Wealth Management with notifications on news.